Trusted sources of information on COVID-19 vaccine in Uganda. 2024

Johnson Nyeko Oloya, and Nelson Onira Alema, and Christopher Okot, and Emmanuel Olal, and Eric Nzirakaindi Ikoona, and Freddy Wathum Drinkwater Oyat, and Baguma Steven, and Denish Omoya Ochula, and Patrick Odong Olwedo, and Francis Pebalo Pebolo, and Pamela Okot Atim, and Godfrey Smart Okot, and Ritah Nantale, and Judith Aloyo, and David Lagoro Kitara
Uganda Medical Association (UMA), UMA-Acholi branch, Gulu City, Uganda.

BACKGROUND The COVID-19 pandemic has dramatically impacted communities worldwide, particularly in developing countries. To successfully control the pandemic, correct information and more than 80% vaccine coverage in a population were required. However, misinformation and disinformation could impact this, thus increasing COVID-19 vaccine hesitancy in communities. Several studies observed the effect of misinformation and disinformation on COVID-19 vaccine acceptance and other responses to the pandemic in the African continent. Thus, the most trusted sources of information on COVID-19 vaccines are critical for the successful management and control of the pandemic. This study aimed to assess the most trusted sources of information on COVID-19 vaccines during the pandemic in Uganda. METHODS We conducted a cross-sectional study on 587 adult population members in northern Uganda. Single-stage stratified and systematic sampling methods were used to select participants from northern Uganda. An interviewer-administered questionnaire with an internal validity of Cronbach's α = 0.72 was used for data collection. An Institution Review Board (IRB) approved this study and Stata version 18 was used for data analysis. A Pearson Chi-square (χ2) analysis was conducted to assess associations between trusted sources of COVID-19 vaccine information and selected independent variables. Fisher's exact test considered associations when the cell value following cross-tabulation was < 5. A P-value < 0.05 was used as evidence for an association between trusted sources of information and independent variables. All results were presented as frequencies, proportions, Chi-square or Fisher's exact tests, and P-values at 95% Confidence Intervals (CI). RESULTS In a study of 587 participants, most were males, 335(57.1%), in the age group of 25-34 years, 180(31.4%), and the most trusted source of COVID-19 vaccine information were the traditional media sources for example, Televisions, Radios, and Newspapers, 349(33.6%). There was no significant association between sex and trusted sources of COVID-19 vaccine information. However, by age-group population, COVID-19 vaccine information was significantly associated with internet use (14.7% versus 85.3%; p = 0.02), information from family members (9.4% versus 90.6%; p < 0.01), and the Government/Ministry of Health (37.9% versus 62.1%; p < 0.01). Between healthcare workers and non-health workers, it was significantly associated with internet use (32.2% versus 67.8%; p = 0.03), healthcare providers (32.5% versus 67.5%; p < 0.018), the Government/Ministry of Health (31.1% versus 68.9%; p < 0.01), and scientific articles (44.7% versus 55.3%; p < 0.01). CONCLUSIONS The most trusted sources of COVID-19 vaccine information in northern Uganda were Televisions, Radios, and Newspapers. The trusted sources of COVID-19 vaccine information were not significantly different between males and females. However, there were significant differences among age groups and occupations of participants with younger age groups (≤ 44 years) and non-healthcare workers having more trust in Televisions, Radios, and Newspapers. Thus, for effective management of an epidemic, there is a need for accurate communication so that misinformation, disinformation, and malinformation in the era of "infodemic" do not disrupt the flow of correct information to communities.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086663 COVID-19 Vaccines Vaccines or candidate vaccines containing SARS-CoV-2 component antigens, genetic materials, or inactivated SARS-CoV-2 virus, and designed to prevent COVID-19. 2019 Novel Coronavirus Vaccine,2019 Novel Coronavirus Vaccines,2019-nCoV Vaccine,2019-nCoV Vaccines,COVID 19 Vaccine,COVID-19 Vaccine,COVID-19 Virus Vaccine,COVID-19 Virus Vaccines,COVID19 Vaccine,COVID19 Vaccines,COVID19 Virus Vaccine,COVID19 Virus Vaccines,Coronavirus Disease 2019 Vaccine,Coronavirus Disease 2019 Vaccines,Coronavirus Disease 2019 Virus Vaccine,Coronavirus Disease 2019 Virus Vaccines,Coronavirus Disease-19 Vaccine,Coronavirus Disease-19 Vaccines,SARS Coronavirus 2 Vaccines,SARS-CoV-2 Vaccine,SARS-CoV-2 Vaccines,SARS2 Vaccine,SARS2 Vaccines,2019 nCoV Vaccine,2019 nCoV Vaccines,COVID 19 Vaccines,COVID 19 Virus Vaccine,COVID 19 Virus Vaccines,Coronavirus Disease 19 Vaccine,Coronavirus Disease 19 Vaccines,SARS CoV 2 Vaccine,SARS CoV 2 Vaccines,Vaccine, 2019-nCoV,Vaccine, COVID 19,Vaccine, COVID-19,Vaccine, COVID-19 Virus,Vaccine, COVID19,Vaccine, COVID19 Virus,Vaccine, Coronavirus Disease-19,Vaccine, SARS-CoV-2,Vaccine, SARS2,Vaccines, 2019-nCoV,Vaccines, COVID-19,Vaccines, COVID-19 Virus,Vaccines, COVID19,Vaccines, COVID19 Virus,Vaccines, Coronavirus Disease-19,Vaccines, SARS-CoV-2,Vaccines, SARS2,Virus Vaccine, COVID-19,Virus Vaccine, COVID19,Virus Vaccines, COVID-19,Virus Vaccines, COVID19
D000088823 Vaccination Hesitancy Delay in acceptance of vaccination despite availability. Vaccination Delay,Vaccine Delay,Vaccine Hesitancy,Delay, Vaccination,Delay, Vaccine,Delays, Vaccination,Delays, Vaccine,Hesitancy, Vaccination,Hesitancy, Vaccine,Vaccination Delays,Vaccination Hesitancies,Vaccine Delays,Vaccine Hesitancies
D000093983 Information Sources Various communications media, information centers, information services that are are utilized to obtain information. Data Source,Information Source,Source of Information,Sources of Information,Data Sources
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

Johnson Nyeko Oloya, and Nelson Onira Alema, and Christopher Okot, and Emmanuel Olal, and Eric Nzirakaindi Ikoona, and Freddy Wathum Drinkwater Oyat, and Baguma Steven, and Denish Omoya Ochula, and Patrick Odong Olwedo, and Francis Pebalo Pebolo, and Pamela Okot Atim, and Godfrey Smart Okot, and Ritah Nantale, and Judith Aloyo, and David Lagoro Kitara
February 2024, Journal of community health,
Johnson Nyeko Oloya, and Nelson Onira Alema, and Christopher Okot, and Emmanuel Olal, and Eric Nzirakaindi Ikoona, and Freddy Wathum Drinkwater Oyat, and Baguma Steven, and Denish Omoya Ochula, and Patrick Odong Olwedo, and Francis Pebalo Pebolo, and Pamela Okot Atim, and Godfrey Smart Okot, and Ritah Nantale, and Judith Aloyo, and David Lagoro Kitara
September 2021, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
Johnson Nyeko Oloya, and Nelson Onira Alema, and Christopher Okot, and Emmanuel Olal, and Eric Nzirakaindi Ikoona, and Freddy Wathum Drinkwater Oyat, and Baguma Steven, and Denish Omoya Ochula, and Patrick Odong Olwedo, and Francis Pebalo Pebolo, and Pamela Okot Atim, and Godfrey Smart Okot, and Ritah Nantale, and Judith Aloyo, and David Lagoro Kitara
December 2021, Vaccines,
Johnson Nyeko Oloya, and Nelson Onira Alema, and Christopher Okot, and Emmanuel Olal, and Eric Nzirakaindi Ikoona, and Freddy Wathum Drinkwater Oyat, and Baguma Steven, and Denish Omoya Ochula, and Patrick Odong Olwedo, and Francis Pebalo Pebolo, and Pamela Okot Atim, and Godfrey Smart Okot, and Ritah Nantale, and Judith Aloyo, and David Lagoro Kitara
April 2021, Behavioral sciences (Basel, Switzerland),
Johnson Nyeko Oloya, and Nelson Onira Alema, and Christopher Okot, and Emmanuel Olal, and Eric Nzirakaindi Ikoona, and Freddy Wathum Drinkwater Oyat, and Baguma Steven, and Denish Omoya Ochula, and Patrick Odong Olwedo, and Francis Pebalo Pebolo, and Pamela Okot Atim, and Godfrey Smart Okot, and Ritah Nantale, and Judith Aloyo, and David Lagoro Kitara
October 2023, Journal of health communication,
Johnson Nyeko Oloya, and Nelson Onira Alema, and Christopher Okot, and Emmanuel Olal, and Eric Nzirakaindi Ikoona, and Freddy Wathum Drinkwater Oyat, and Baguma Steven, and Denish Omoya Ochula, and Patrick Odong Olwedo, and Francis Pebalo Pebolo, and Pamela Okot Atim, and Godfrey Smart Okot, and Ritah Nantale, and Judith Aloyo, and David Lagoro Kitara
March 2024, American journal of health promotion : AJHP,
Johnson Nyeko Oloya, and Nelson Onira Alema, and Christopher Okot, and Emmanuel Olal, and Eric Nzirakaindi Ikoona, and Freddy Wathum Drinkwater Oyat, and Baguma Steven, and Denish Omoya Ochula, and Patrick Odong Olwedo, and Francis Pebalo Pebolo, and Pamela Okot Atim, and Godfrey Smart Okot, and Ritah Nantale, and Judith Aloyo, and David Lagoro Kitara
June 2022, Vaccines,
Johnson Nyeko Oloya, and Nelson Onira Alema, and Christopher Okot, and Emmanuel Olal, and Eric Nzirakaindi Ikoona, and Freddy Wathum Drinkwater Oyat, and Baguma Steven, and Denish Omoya Ochula, and Patrick Odong Olwedo, and Francis Pebalo Pebolo, and Pamela Okot Atim, and Godfrey Smart Okot, and Ritah Nantale, and Judith Aloyo, and David Lagoro Kitara
December 2021, BMC public health,
Johnson Nyeko Oloya, and Nelson Onira Alema, and Christopher Okot, and Emmanuel Olal, and Eric Nzirakaindi Ikoona, and Freddy Wathum Drinkwater Oyat, and Baguma Steven, and Denish Omoya Ochula, and Patrick Odong Olwedo, and Francis Pebalo Pebolo, and Pamela Okot Atim, and Godfrey Smart Okot, and Ritah Nantale, and Judith Aloyo, and David Lagoro Kitara
September 2023, Journal of health communication,
Johnson Nyeko Oloya, and Nelson Onira Alema, and Christopher Okot, and Emmanuel Olal, and Eric Nzirakaindi Ikoona, and Freddy Wathum Drinkwater Oyat, and Baguma Steven, and Denish Omoya Ochula, and Patrick Odong Olwedo, and Francis Pebalo Pebolo, and Pamela Okot Atim, and Godfrey Smart Okot, and Ritah Nantale, and Judith Aloyo, and David Lagoro Kitara
April 2022, Currents in pharmacy teaching & learning,
Copied contents to your clipboard!